Overview of Dr. Goldsmith
Dr. Scott Goldsmith is a hematologist in Duarte, CA and is affiliated with City of Hope Comprehensive Cancer Center. He received his medical degree from University of Florida College of Medicine and has been in practice 4 years. He is one of 47 doctors at City of Hope Comprehensive Cancer Center who specialize in Hematology. He has more than 30 publications and over 400 citings.
Office
Department of Hematology & HCT
1500 East Duarte Road
Duarte, CA 91010Fax+1 626-389-3058- Is this information wrong?
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2013 - 2016
University of Florida College of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2021 - 2025
MO State Medical License 2015 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma Start of enrollment: 2022 Nov 22
- A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma Start of enrollment: 2021 Nov 11
Publications & Presentations
PubMed
- 3 citationsEvolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future DirectionsScott R. Goldsmith, Ravi Vij
JCO Oncology Practice. 2021-06-10 - 73 citationsEpidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.Michael Slade, Scott R. Goldsmith, Rizwan Romee, John F. DiPersio, Erik R. Dubberke
Transplant Infectious Disease. 2017-02-01 - 7 citationsSingle-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.Lijun Yao, Julia T Wang, Reyka G Jayasinghe, Julie O'Neal, Chia-Feng Tsai
Cancer Research. 2023-04-14
Abstracts/Posters
- Dysregulated Mirnas after Uniform Treatment Predict Outcome of Newly-Diagnosed Multiple MyelomaScott R. Goldsmith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Dramatic Resolution of HLH after Treatment with the JAK 1/2 Inhibitor, Ruxolitinib61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Ire of IRE1_: Overexpression of IRE1_ at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1_ Expression Is Predictive of Therapy ...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
